07 Jan 2001

Corvaton® 2 (Corvaton® 2 mg/-forte 4 mg Tabletten) - Deutschland

Updated: 07 Jan 2001

Corvaton® 2 mg | -forte 4 mg | -retard 8 mg Tabletten

Stabile und instabile Angina pectoris bei gleichzeitig bestehender Linksherzinsuffizienz, Angina pectoris im akuten Stadium des Herzinfarkts (erst nach Stabilisierung des Kreislaufs), Angina pectoris, wenn andere Arzneimittel nicht angezeigt sind, nicht vertragen wurden oder nicht ausreichend wirksam waren, sowie bei Patienten in höherem Lebensalter. Bei schwerer chronischer Herzinsuffizienz in Kombination mit Digitalis und/oder harntreibenden Mitteln. Pulmonale Hypertonie.

Corvaton® 2 Description, Presentation and Dosage

Corvaton® 2 Description

Corvaton® 2 Drug Class Description


Corvaton® 2 Drug Description

1 Tbl. enth.: Molsidomin 2 mg/4 mg.

Corvaton® 2 Generic Name

Corvaton® 2 mg/-forte 4 mg Tabletten

Corvaton® 2 Presentation

Corvaton® 2 Presentation

Corvaton® 2 mg/-forte 4 mg/-retard 8 mg Tabletten

Corvaton® 2 Manufacturer

Aventis Pharma

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.


Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Corvaton® 2 Dosage

Corvaton® 2 Adult Dosage

Crospovidon, Lactose, Macrogol 6000, Magnesiumstearat.

Corvaton® 2 Child Dosage

Corvaton® retard 8 mg Tabletten
Zus.: 1 Retardtbl. enth.: Molsidomin 8 mg.
Weit. Bestandteile: Mikrokristalline Cellulose, Lactose, Macrogol 6000, Magnesiumstearat, hydriertes Rizinusöl.

Corvaton® 2 Precautions, Reactions and Contraindications

Corvaton® 2 Special Precautions

Corvaton® 2 Special Precautions

M 39. Gleichz. Anw. mit Sildenafil.

Corvaton® 2 Adverse Reactions

Corvaton® 2 Adverse Reactions

Strenge Ind.-Stellung i. 1. Trim. Gr 4 .

Related Drugs - Angiology

Back to top